Integrated Neuromuscular Inhibition Technique Versus Kinesiotap On Upper Trapezius Myofascial trigger points: Randomised Clinical Trial

integrated neuromuscular inhibition technique versus kinesiotape on pain intensity, pressure pain threshold, range of motion,functional disability and electrical activity of muscle ( muscle amplitude and fatigue) in patient with myofascial trigger points

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201701001962265

Enrollment

Registered

2017-01-05

Start date

2017-02-01

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myofascial trigger points

Interventions

integrated neuromuscular inhibition technique

kinesiotape

advices

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1-All patients have active MTrPs in upper trapezius muscle unilaterally. 2-The patients have pain at rest, local twitch response, jump sign, limited ROM and referred (Fryer and Hodgson, 2005). 3-The patients aged will be ranged from 19 to 38 years. 4-The patients will be chosen from both sexes 5-All patients medically stable and do not suffer from any other diseases which might affect the trial results.

Exclusion criteria

Exclusion criteria: 1-History of whiplash injury. 2-History of cervical spine surgery. 3-Cervical radiculopathy or myelopathy. 4-Having undergone physical therapy within the past 3 months before the study. 5-Non- rheumatologic diseases as multiple sclerosis, thyroid dysfunction and chronic infection.

Design outcomes

Primary

Measure	Time frame
pain intensity;pressure pain threshold;range of motion;functional disability	—

Secondary

Measure	Time frame
electrical activity of the muscle	—

Countries

Egypt

Contacts

Public Contactsalah Eldein bassit

utcsalah@gmail.com01115018299

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026